BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

Abstract

Our findings may reflect higher platinum-sensitivity due to reduced capacity of DNA damage repair in tissues with low BRCA1/2-expression. In this context, especially in BRCA-wildtype cancers both parameters could also be potential predictors for PARP-sensitivity.